| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 147, 782-789, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
MB Juckett, J Balla, G Balla, J Jessurun, HS Jacob and GM Vercellotti
Department of Medicine, University of Minnesota, Minneapolis, USA.
Low density lipoprotein (LDL), if it becomes oxidized, develops several unique properties including the capacity to provoke endothelial cytotoxicity via metal-catalyzed free radical-mediated mechanisms. As were previously have shown that iron-catalyzed oxidant injury to endothelial cells can be attenuated by the addition of exogenous iron chelators such as the lazaroids and deferoxamine, we have examined whether the endogenous iron chelator, ferritin, might provide protection from oxidized LDL. LDL oxidized by iron-containing hemin and H2O2 is toxic to endothelial cells in a time- and dose-dependent fashion. Endothelial cell ferritin content is increased by pretreatment of cells with iron compounds or by the direct addition of exogenous apoferritin; ferritin-loaded cells are markedly resistant to the toxicity caused by oxidized LDL. Iron inactivation by ferritin depends on its ferroxidase activity. When a recombinant human ferritin heavy chain mutant, 222, which is devoid of ferroxidase activity, is added to endothelial cells, unlike the excellent protection afforded by the wild- type recombinant heavy chain, endothelial cells are not protected from oxidized LDL. To assess the in vivo relevance of our observation, we examined human coronary arteries of cardiac explants taken from patients with end-stage atherosclerosis. Large amounts of immunoreactive ferritin are focally detected in atherosclerotic lesions, specifically in the myofibroblasts, macrophages, and endothelium without a notable increase in Prussian blue-detectable iron. These findings suggest that ferritin may modulate vascular cell injury in vivo.
This article has been cited by other articles:
 |
|
 |
|
  K. Erdmann, N. Grosser, K. Schipporeit, and H. Schroder The ACE Inhibitory Dipeptide Met-Tyr Diminishes Free Radical Formation in Human Endothelial Cells via Induction of Heme Oxygenase-1 and Ferritin J. Nutr., August 1, 2006; 136(8): 2148 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. LEVINE and A. CHAKRABARTY The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis Ann. N.Y. Acad. Sci., March 1, 2004; 1012(1): 252 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, Y. Higashi, H. Itabe, Y.-H. Song, J. Du, and P. Delafontaine Insulin-Like Growth Factor-1 Receptor Activation Inhibits Oxidized LDL-Induced Cytochrome C Release and Apoptosis via the Phosphatidylinositol 3 Kinase/Akt Signaling Pathway Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2178 - 2184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Balla, G. M. Vercellotti, K. Nath, A. Yachie, E. Nagy, J. W. Eaton, and G. Balla Haem, haem oxygenase and ferritin in vascular endothelial cell injury Nephrol. Dial. Transplant., July 1, 2003; 18(90005): v8 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart Cross-Talk Between Iron Metabolism and Diabetes Diabetes, August 1, 2002; 51(8): 2348 - 2354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Jeney, J. Balla, A. Yachie, Z. Varga, G. M. Vercellotti, J. W. Eaton, and G. Balla Pro-oxidant and cytotoxic effects of circulating heme Blood, July 18, 2002; 100(3): 879 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Balla, G. Balla, V. Jeney, G. Kakuk, H. S. Jacob, and G. M. Vercellotti Ferriporphyrins and endothelium: a 2-edged sword---promotion of oxidation and induction of cytoprotectants Blood, June 1, 2000; 95(11): 3442 - 3450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Walsh and J. M. Isner Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall Cardiovasc Res, February 1, 2000; 45(3): 756 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. de Valk and J. J. M. Marx Iron, Atherosclerosis, and Ischemic Heart Disease Arch Intern Med, July 26, 1999; 159(14): 1542 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sata and K. Walsh Endothelial Cell Apoptosis Induced by Oxidized LDL Is Associated with the Down-regulation of the Cellular Caspase Inhibitor FLIP J. Biol. Chem., December 11, 1998; 273(50): 33103 - 33106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Juckett, Y. Zheng, H. Yuan, T. Pastor, W. Antholine, M. Weber, and G. Vercellotti Heme and the Endothelium. EFFECTS OF NITRIC OXIDE ON CATALYTIC IRON AND HEME DEGRADATION BY HEME OXYGENASE J. Biol. Chem., September 4, 1998; 273(36): 23388 - 23397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ujhelyi, J. Balla, L. Muszbek, G. Kakuk, J. Belcher, H. S. Jacob, G. M. Vercellotti, and G. Balla A Microassay to Assess the Oxidative Resistance of Low-Density Lipoproteins Clin. Chem., August 1, 1998; 44(8): 1762 - 1764. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Y. Calingasan, L. C. H. Park, L. L. Calo, R. R. Trifiletti, S. E. Gandy, and G. E. Gibson Induction of Nitric Oxide Synthase and Microglial Responses Precede Selective Cell Death Induced by Chronic Impairment of Oxidative Metabolism Am. J. Pathol., August 1, 1998; 153(2): 599 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oberle, T. Polte, A. Abate, H.-P. Podhaisky, and H. Schroder Aspirin Increases Ferritin Synthesis in Endothelial Cells : A Novel Antioxidant Pathway Circ. Res., May 19, 1998; 82(9): 1016 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Holvoet, J.-M. Stassen, J. Van Cleemput, D. Collen, and J. Vanhaecke Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., January 1, 1998; 18(1): 100 - 107. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
